Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.08M Sell
20,118
-4,962
-20% -$1.77M 0.13% 178
2025
Q4
$8.21M Sell
25,080
-2,374
-9% -$753K 0.14% 173
2025
Q3
$7.75M Sell
27,454
-2,697
-9% -$782K 0.14% 168
2025
Q2
$8.42M Buy
30,151
+1,549
+5% +$439K 0.16% 161
2025
Q1
$8.91M Sell
28,602
-13,083
-31% -$3.86M 0.22% 136
2024
Q4
$10.9M Sell
41,685
-7,485
-15% -$2.22M 0.25% 127
2024
Q3
$15.8M Sell
49,170
-1,681
-3% -$550K 0.36% 80
2024
Q2
$15.9M Sell
50,851
-3,214
-6% -$944K 0.38% 77
2024
Q1
$15.4M Sell
54,065
-630
-1% -$184K 0.35% 87
2023
Q4
$15.8M Sell
54,695
-2,963
-5% -$807K 0.48% 63
2023
Q3
$15.5M Buy
57,658
+384
+0.7% +$95.8K 0.53% 63
2023
Q2
$12.7M Sell
57,274
-371
-0.6% -$86.1K 0.42% 74
2023
Q1
$13.9M Sell
57,645
-1,832
-3% -$450K 0.49% 64
2022
Q4
$15.6M Sell
59,477
-3,467
-6% -$929K 0.56% 58
2022
Q3
$14.2M Sell
62,944
-3,615
-5% -$876K 0.53% 63
2022
Q2
$16.2M Sell
66,559
-3,283
-5% -$805K 0.56% 58
2022
Q1
$16.9M Buy
69,842
+2,978
+4% +$684K 0.53% 59
2021
Q4
$15M Buy
66,864
+631
+1% +$133K 0.45% 67
2021
Q3
$14.1M Buy
66,233
+3,720
+6% +$856K 0.46% 62
2021
Q2
$15.2M Buy
62,513
+1,512
+2% +$372K 0.51% 57
2021
Q1
$15.2M Buy
61,001
+1,030
+2% +$246K 0.56% 54
2020
Q4
$13.8M Buy
59,971
+7,138
+14% +$1.65M 0.5% 54
2020
Q3
$13.4M Sell
52,833
-114
-0.2% -$28.2K 0.58% 46
2020
Q2
$12.5M Sell
52,947
-4,578
-8% -$1.04M 0.55% 45
2020
Q1
$11.7M Sell
57,525
-12,560
-18% -$2.74M 0.55% 44
2019
Q4
$16.9M Sell
70,085
-5,925
-8% -$1.31M 0.47% 49
2019
Q3
$14.7M Sell
76,010
-902
-1% -$173K 0.39% 65
2019
Q2
$14.2M Sell
76,912
-1,724
-2% -$309K 0.36% 75
2019
Q1
$14.9M Sell
78,636
-7,134
-8% -$1.36M 0.38% 63
2018
Q4
$16.7M Buy
85,770
+455
+0.5% +$88.8K 0.43% 60
2018
Q3
$17.7M Sell
85,315
-550
-0.6% -$108K 0.42% 66
2018
Q2
$15.8M Sell
85,865
-6,784
-7% -$1.2M 0.38% 72
2018
Q1
$15.8M Buy
92,649
+7,788
+9% +$1.43M 0.4% 60
2017
Q4
$14.8M Buy
84,861
+3,679
+5% +$651K 0.38% 68
2017
Q3
$15.1M Sell
81,182
-2,999
-4% -$531K 0.39% 67
2017
Q2
$14.5M Sell
84,181
-143
-0.2% -$23.3K 0.41% 58
2017
Q1
$13.8M Buy
84,324
+1,753
+2% +$291K 0.57% 50
2016
Q4
$12.1M Buy
82,571
+12,072
+17% +$1.82M 0.65% 53
2016
Q3
$11.8M Buy
70,499
+18,906
+37% +$3.2M 0.64% 47
2016
Q2
$7.85M Sell
51,593
-1,301
-2% -$202K 0.41% 69
2016
Q1
$7.93M Buy
52,894
+48,547
+1,117% +$7.21M 0.52% 63
2015
Q4
$706K Buy
4,347
+44
+1% +$6.92K 0.03% 268
2015
Q3
$595K Sell
4,303
-18
-0.4% -$2.84K 0.04% 303
2015
Q2
$663K Sell
4,321
-59
-1% -$9.45K 0.04% 267
2015
Q1
$700K Buy
4,380
+700
+19% +$110K 0.04% 301
2014
Q4
$586K Sell
3,680
-534
-13% -$83.2K 0.04% 332
2014
Q3
$592K Buy
4,214
+32
+0.8% +$4.18K 0.04% 334
2014
Q2
$495K Hold
4,182
0.03% 326
2014
Q1
$516K Buy
4,182
+534
+15% +$64.8K 0.04% 272
2013
Q4
$416K Sell
3,648
-150
-4% -$17.1K 0.03% 261
2013
Q3
$425K Buy
3,798
+683
+22% +$74.1K 0.03% 267
2013
Q2
$307K Buy
+3,115
New +$323K 0.02% 285

Other funds holding AMGN

Curi RMB Capital's AMGN Position: Q1 2026 in Review

Curi RMB Capital reduced its Amgen (AMGN) stake by 20% in Q1 2026, selling an estimated $1.77M and leaving 20,118 shares worth $7.08M. The position accounts for 0.13% of the portfolio, ranked #178.

Curi RMB Capital first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.7M in Q3 2018. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Curi RMB Capital held 20,118 shares of Amgen worth $7.08M as of Q1 2026.
  • Curi RMB Capital sold 4,962 Amgen shares in Q1 2026, an estimated $1.77M.
  • Amgen made up 0.13% of Curi RMB Capital's portfolio in Q1 2026, its #178 holding.
  • Curi RMB Capital first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Curi RMB Capital's Amgen position peaked at $17.7M in Q3 2018.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.